Interphex on Tap - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Interphex on Tap
The 2011 show presents ideas for package designs and equipment options for packaging lines.


Pharmaceutical Technology
Volume 35, Issue 3, pp. 44-48

Single-use systems


Symetix Secure Connection enables remote diagnostics for VeriSym and OptyxSG inspection systems. (PHOTO IS COURTESY OF SYMETIX.)
A range of end-ported biocontainers meet the growing demand for single-use systems that reduce cleaning requirements and downtime. Available in 50-, 250-, and 500-mL sizes as well as 1-, 2-, 5-, 10-, and 20-L sizes, the polyethylene-based containers offer high gas and water-vapor barrier properties. Custom designs also are available. Biocontainers may be ordered with silicone or thermoplastic elastomer tubing with various connections, and can be specified with or without filter capsules. Certified to be free of animal components, the containers are packaged in an ISO Class 7 cleanroom (TepoFlex biocontainers, Meissner Filtration Products).

Quality-control devices

A direct connection between machine and machine builder provides remote access to inspection equipment even if the system is located behind a firewall. The secure link enables remote diagnostics to be conducted and supplies data, images, and other information. If permission is granted, original equipment company engineers can access the machine's user interface, data, images, and logs. Setup is simple and saves the days of engineering and administrative time usually needed to provide access to a machine.

The connection also archives logs and setup parameters securely and makes it possible to transmit logs and batch records to any computer with a network connection. The connection service can be purchased alone or as part of a service package that includes replacement parts and an annual on-site machine audit by a field engineer (Symetix Secure Connection service for VeriSym and OptyxSG inspection systems, Symetix).

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,
.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What impact do mega-mergers of biopharmaceutical companies have on the development of new drugs?
Improves the quality and number of innovative drugs available to patients.
Restricts innovation and the development of new drugs.
Has no impact on drug development.
Do not know.
Improves the quality and number of innovative drugs available to patients.
29%
Restricts innovation and the development of new drugs.
54%
Has no impact on drug development.
4%
Do not know.
13%
Eric Langer Outsourcing Outlook Eric LangerOutsourcing No Longer Just for Cost-Cutting
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerSeeking Alternative Catalyst Solutions
Jill Wechsler Regulatory Watch Jill Wechsler Global Expansion Shapes Drug Oversight
Chris Burgess Statistical Solutions Chris BurgessIs a Sample Size of n=6 a Magic Number?
Sean Milmo European Regulatory WatchSean MilmoRegulating the Environmental Impact of Pharmaceuticals
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Source: Pharmaceutical Technology,
Click here